A massive Danish study involving nearly 50,000 patients suggests that a first seizure may be an early warning sign of hidden cancer. Researchers found that people experiencing their first seizure have a dramatically elevated risk of developing cancer within the following year, especially brain cancer. The findings, published in JAMA Neurology by Andreas L. P. and colleagues, paint a stark picture: a first seizure could indicate that a hidden malignancy is already developing.
Study Overview
The scale of the problem is staggering. Among the 49,894 adults tracked in the study, with a median age of 51.5 years, more than 2,000 cancer cases emerged within the first 12 months following a seizure. For neurological cancers, such as brain tumors, the standardized incidence ratio hit 76.1. This means that people who had a first seizure were 76 times more likely to develop brain cancer compared to the general population. For non-neurological cancers, the risk was 2.32 times higher, and any type of cancer showed a 5.30-fold increased risk in that critical first year.
Timing Matters
What makes this finding so important is timing. During the first year, 1,172 neurological cancers and 850 non-neurological cancers were diagnosed in the study population. After that first year, the risks decreased significantly. From year one through five, the risk settled to 1.18 times the general population. By years five through 20, it rose slightly to 1.34 times. But nothing compared to the explosive first year.
Implications for Patients
The implications are troubling for patients who have had unexplained seizures. They might go home thinking their seizure was a one-off event, something to manage with medication and follow-up appointments. However, this study suggests they should be getting aggressive cancer screening, not just brain imaging to look for tumors, but also full body assessment, blood work, and comprehensive oncology evaluation. The seizure was not the disease; it was the symptom of something hiding.
Methodology
Researchers used Denmark's comprehensive registry system to track these patients with exceptional precision, following them either until cancer diagnosis, death, or emigration. The data was clean, reliable, and impossible to ignore. Nearly 42% of the study population were women, meaning this risk applies across genders equally.
Clinical Takeaway
The clinical takeaway is straightforward: if you have a first seizure, especially as an adult, you need to take it seriously, not just neurologically, but as a potential marker for cancer. The authors of the study emphasized this in their findings. The high concentration of cancer risk in that first year demands a shift in how doctors approach new-onset seizures. Standard neurological workup is not enough anymore; these patients need comprehensive cancer screening.
It is a reminder that sometimes a single symptom is never just one thing. Sometimes it is your body's way of saying something else is already wrong. And sometimes the symptom that scares you initially might not be the problem you should actually fear.
